EU's Advisory Panel Clears BMS/Pfizer's Apixaban; Turns Down Vectibix Extension

Europe's scientific advisory committee, the CHMP, gives positive opinions on apixaban and Viropharma's Cinryze, but doesn't want Vectibix's indications extended.

More from Archive

More from Pink Sheet